Kolexia
Wils Pauline Gastro-entérologie
Wils Pauline
Gastro-entérologie
Hôpital Huriez
Lille, France
84 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie de Crohn Maladies inflammatoires intestinales Colite Rectocolite hémorragique Nécrose Sténose pathologique Fistule rectale Infections à Escherichia coli Iléite

Collaborateurs

Voir plus
Fumery Mathurin
Fumery Mathurin
Centre Hospitalier D'Amiens Salouël Site Sud, Salouël, France
Nachury Maria
Nachury Maria
Hôpital Huriez, Lille, France
Pariente Benjamin
Pariente Benjamin
Hôpital Huriez, Lille, France
Buisson Anthony
Buisson Anthony
Hôpital Estaing, Clermont-Ferrand, France

Industries

Voir plus
Abbvie
19 collaboration(s)
Dernière en 2023
Edimark
7 collaboration(s)
Dernière en 2023
Ferring
5 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
5 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Infliximab is an effective option in patients with ulcerative colitis previously exposed to full subcutaneous anti-TNF agent: Results from a real-world multicenter study.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   27 janvier 2024
Histological healing induced by tofacitinib in ulcerative colitis: A multicentre study.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   07 décembre 2023
Long-term effectiveness and acceptability of switching from intravenous to subcutaneous infliximab in patients with inflammatory bowel disease treated with intensified doses: The REMSWITCH-LT study.
Alimentary pharmacology & therapeutics   30 novembre 2023
A Novel 8-Predictors Signature to Predict Complicated Disease Course in Pediatric-onset Crohn's Disease: A Population-based Study.
Inflammatory bowel diseases   08 novembre 2023
Washout Periods in Inflammatory Bowel Disease Trials: A Systematic Literature Review and Proposed Solutions.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association   22 septembre 2023
Comparison of treatment effect between phase 2 and phase 3 trials in patients with inflammatory bowel disease.
United European gastroenterology journal   05 septembre 2023
Anti-IL-23 dans les MICI : qui est qui ?
Edimark   31 août 2023
A comparison of treatment effect sizes in matched phase 2 and phase 3 trials of advanced therapeutics in inflammatory bowel disease: systematic review and meta-analysis.
Clinical and translational gastroenterology   14 août 2023
New Therapeutic Strategies Are Associated With a Significant Decrease in Colectomy Rate in Pediatric Ulcerative Colitis.
The American journal of gastroenterology   02 juin 2023
Promising phase II biologics for future Crohn's disease therapy.
Expert opinion on investigational drugs   31 mai 2023